SEARCH

SEARCH BY CITATION

References

  • 1
    Hepatitis B virus: A comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination. Recommendations of the immunization practices advisory committee (ACIP). Morb Mortal Wkly Rep 1991; 40:119.
  • 2
    Lemon SL, Thomas DL. Vaccines to prevent viral hepatitis. N Engl J Med 1997; 336:196204.MEDLINE
  • 3
    Huang EF, Wright TL, Lake JR, Combs C, Ferrell LD. Hepatitis B and C coinfections and persistent hepatitis B infections: Clinical outcome and liver pathology after transplantation. Hepatology 1996; 23:396404.MEDLINE
  • 4
    Van Thiel DH, El-Ashmawy L, Love K, Gavaler JS, Starzl TE. Response to hepatitis B vaccination by liver transplant candidates. Dig Dis Sci 1992; 37:12451249.MEDLINE
  • 5
    Carey W, Pimentel R, Westveer MK, Vogt D, Broughan T. Failure of hepatitis B immunization in liver transplant recipients: Results of a prospective trial. Am J Gastroenterol 1990; 85:15901592.MEDLINE
  • 6
    Loinaz C, de Juanes JR, Gonzalez EM, Lopez A, Lumbreras C, Gomez R, et al. Hepatitis B vaccination results in 140 liver transplant recipients. Hepatogastroenterology 1997; 44:235238.MEDLINE
  • 7
    Wood RC, MacDonald KL, White KE, Hedberg CW, Hanson M, Osterholm MT. Risk factors for lack of detectable antibody following hepatitis B vaccination of Minnesota health workers. JAMA 1993; 270:29352939.MEDLINE
  • 8
    Shaw FE, Guess HA, Roets JM, Mohr FE, Coleman PJ, Mandel EJ, et al. Effect of anatomic injection site, age and smoking on the immune response to hepatitis B vaccination. Vaccine 1989; 7:425430.MEDLINE
  • 9
    Johnson DW, Fleming SJ. The use of vaccines in renal failure. Clin Pharmacokinet 1992; 22:434446.MEDLINE
  • 10
    Stevens CE, Alter HJ, Taylor PE, Zang EA, Harley EJ, Szmuness W. Dialysis Vaccine Trial Study Group. Hepatitis B vaccine in patients receiving hemodialysis: Immunogenicity and efficacy. N Engl J Med 1984; 311:496501.MEDLINE
  • 11
    Crosnier J, Junger P, Courouce AM, Laplanche A, Benhamou E, Degos F, et al. Randomized placebo controlled trial of hepatitis B surface antigen vaccine in French hemodialysis units: II hemodialysis patients. Lancet 1981; 1:797800.MEDLINE
  • 12
    Weitberg AB, Wietzman SA, Watkins E, Hinkle C, O'Rourke S, Dienstag JL. Immunogenicity of hepatitis B vaccine in oncology patients receiving chemotherapy. J Clin Oncol 1985; 3:718722.MEDLINE
  • 13
    Collier AC, Corey L, Murphy VL, Handsfield HH. Antibody to human immunodeficiency virus (HIV) and suboptimal response to hepatitis B vaccination. Ann Intern Med 1988; 109:101105.MEDLINE
  • 14
    Manucci PM, Zanetti AR, Gringeri A, Tanzi E, Morfini M, Messori A, et al. Long-term immunogenicity of a plasma derived hepatitis B vaccine in HIV seropositive and HIV seronegative hemophiliacs. Arch Intern Med 1989; 149:13331337.MEDLINE
  • 15
    Brugera M, Cremades M, Salinas R, Costa J, Grau M, Sans J. Impaired response to recombinant hepatitis B vaccine in HIV-infected persons. J Clin Gastroenterol 1992; 14:2730.MEDLINE
  • 16
    Mendenhall C, Roselle GA, Lybecker LA, Marshall LE, Grossman CJ, Myre SA, et al. Hepatitis B vaccination. Response of alcoholic with and without liver injury. Dig Dis Sci 1988; 33:263269.MEDLINE
  • 17
    Degos F, Duhamel G, Brechot C, Nalpas B, Courouce AM, Tron F, et al. Hepatitis B vaccination in chronic alcoholics. J Hepatol 1986; 2:402409.MEDLINE
  • 18
    Sokal EM, Ulla L, Otte JB. Hepatitis B vaccine response before and after transplantation in 55 extrahepatic biliary atresia children. Dig Dis Sci 1992; 37:12501252.MEDLINE
  • 19
    Berner J, Kadian M, Post J, Miller C, Schwartz M, Conn M, et al. Prophylactic recombinant hepatitis B vaccine in patients undergoing orthotopic liver transplantation. Transplant Proc 1993; 25:17511752.MEDLINE
  • 20
    Meyer zum Buschenfelde K-H, Gerken G. Immune mechanisms in the production of liver disease. In: ZakimD, BoyerTD, eds. Hepatology. A textbook of liver disease. 3rd ed. Philadelphia: Saunders, 1996;12431258.
  • 21
    Keeffe EB, McMahon BJ, Koff RS, Lindsay KL, Manns M, Ivarson S, et al. Safety and immunogenicity of hepatitis A vaccine in patients with chronic liver disease [abstract]. Gastroenterology 1996; 110:A1231.
  • 22
    McCashland TM, Gentry MF, Preheim LC. Pneumococcal vaccine response is reduced by cirrhosis and liver transplantation [abstract]. Hepatology 1996; 24:A305.
  • 23
    Jacobson IM, Jaffers G, Dienstag JL, Tolkoff-Rubin NE, Cosimi AB, Delmonico F, et al. Immunogenicity of hepatitis B vaccine in renal transplant recipients. Transplantation 1985; 39:393395.MEDLINE
  • 24
    Buti M, Viladomiu L, Jardi R, Olmos A, Rodriguez JA. Long-term immunogenicity and efficacy of hepatitis B vaccine in hemodialysis patients. Am J Nephrol 1992; 12:144147.MEDLINE
  • 25
    Wachs ME, Amend WJ, Ascher NL, Bretan PN, Emond J, Lake JR, et al. The risk of transmission of hepatitis B from HBsAg (−), HBcAb (+), HBIgM (−) organ donors. Transplantation 1995; 59:230234.MEDLINE
  • 26
    Douglas DD, Rakela J, Mamish D, Wright TL, Krom RAF, Weisner RH. Transmission of hepatitis B virus (HBV) infection from orthotopic donor livers [abstract]. Hepatology 1992; 16:49A.
  • 27
    Roche B, Samuel D, Gigou M, Feray C, Virot V, Schmets L, et al. De novo and apparent de novo hepatitis B virus infection after liver transplantation. J Hepatology 1997; 26:517526.
  • 28
    Schreiber GB, Busch MP, Kleinman SH, Korelitz JJ. The risk of transfusion transmitted viral infections. N Engl J Med 1996; 334:16851690.MEDLINE